Maravai LifeSciences Q4 revenue drops less than expected
Overview
Life science reagents provider reported smaller-than-expected drop in Q4 revenue
Adjusted EBITDA for Q4 beat analyst expectations
Revenue decline due to reduced CleanCap orders for vaccine programs
Outlook
Maravai expects full-year 2026 revenue between $200 mln and $210 mln
Company projects full-year 2026 Adjusted EBITDA between $18 mln and $20 mln
Result Drivers
CLEANCAP ORDERS - TriLink segment revenue fell 17.4% in Q4 due to reduced CleanCap orders for vaccine programs
HCP KITS DEMAND - Cygnus segment revenue increased 4.1% in Q4 driven by strong demand for HCP kits
COST REDUCTION - Positive Adjusted EBITDA in Q4 attributed to organizational restructuring and cost reduction
Company press release: ID:nBwpLk9Ca
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Beat | $49.90 mln | $49.05 mln (11 Analysts) |
Q4 Net Income |
| -$63 mln |
|
Q4 Adjusted EBITDA | Beat | $500,000 | -$4.02 mln (10 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy"
Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $4.50, about 44.2% above its February 24 closing price of $3.12
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
Related Articles
Circle Stock Price Outlook: Will Circle Internet Group Rebound in 2026?
TradingKey - Circle Internet Group (CRCL) saw its stock price experience a roller coaster ride since its 2025 IPO debut at $31 a share. Those early fireworks faded, and the shares now sit roughly 75% below their June peak, though they’re still more than double the IPO level. Outside of that first-mo
Paramount Offers High Price Again to Bid for Warner Bros., Netflix Acquisition Hits Twists and Turns.
TradingKey - Hollywood media group Warner Bros. (WBD) announced Tuesday that it has received a revised acquisition proposal from Paramount (PSKY), raising the offer from the previous $30 to $31 per share in cash. The Board of Directors stated that this new bid "is likely to constitute a superior proposal" to the current agreement with Netflix and noted that negotiations between the two parties are continuing. The existing deal with Netflix (NFLX) remains in effect, as the Warner Bros. Board has not yet formally designated the Paramount offer as the superior proposal.
Nvidia Q4 Earnings: Market Fears Competition, but NVDA Moat is Beyond CUDA
All eyes are on Nvidia this week, as the company reports its 2026Q4 earnings.
Nvidia Q4 Earnings Preview: AI-Driven Growth Versus Market Expectations
TradingKey - NVIDIA (NVDA) is set to release its fourth quarter fiscal year 2026 earnings report after the market close on February 25, ET. As the world undergoes a period of rapid AI technological advancement, market debates over a capital expenditure bubble have intensified. In this context, NVIDIA’s results serve not only as a test of its business performance but also as a core bellwether for the sustainability of the global AI boom.
